Skip to content
ppharmaranks
Menu
Class IIOngoing

Furosemide Tablets recall

FDA recall D-0293-2026 · initiated Jan 10, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jan 28, 2026How we research

Graviti Pharmaceuticals Private Limited recalled Furosemide Tablets in Jan 2026 — an FDA Class II recall (D-0293-2026) because Presence of Foreign Substance.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Foreign Substance

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot# FUB125042G; Exp. 05/13/2027

Quantity recalled: 4212 bottles

Details

Product
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Recalling company
Graviti Pharmaceuticals Private Limited
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide
Initiated
Jan 10, 2026
FDA report date
Jan 28, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Furosemide Tablets recalled?
Graviti Pharmaceuticals Private Limited recalled Furosemide Tablets in Jan 2026 — an FDA Class II recall (D-0293-2026) because Presence of Foreign Substance. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Furosemide Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0293-2026 was: Presence of Foreign Substance
Is a recalled Furosemide Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Furosemide Tablets are affected?
Distributed: U.S. Nationwide. The recall covers these lots — Lot# FUB125042G; Exp. 05/13/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0293-2026.

Source: openFDA Drug Enforcement record D-0293-2026

← All drug recalls